HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Nippon India Pharma Fund - Direct (G) vs Nippon India Value Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs Nippon India Value Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

16.48%

stock2

Nippon India Value Fund - Direct (G)

7.95%

Graph not available
Graph not available

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

8080.97

1.12

552.45

January 1, 2013

1

Very High Risk

500

8101.08

0.96

235.0965

January 1, 2013

0

23.61 %

21.09 %

16.48 %

30.71 %

21.86 %

7.95 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Meenakshi Dawar

B.Tech From IGIT New Delhi,PGDM From IIM Ahmedabad.,

Reliance Nippon Life Asset Management Limited (From March 01, 2017) - Fund Manager - Equity. IDFC Mutual Fund - Fund Manager managing Large Cap and Hybrid Funds (June 2011 - February 2017) ICICI Securities - Equity Research Analyst covering listed Indian Equities. Also led an initiative to expand research coverage for mid and small cap companies (April 2010 - June 2011) Edelweiss Capital - Associate - Relationship manager for domestic mutual funds and insurance companies (May 2008 - March 2010)

Omprakash Kuckian

B.Com., AICWA

Mr. Kuckian is a B.Com (H) and AICWA.Prior to joining Religare Invesco AMC he has worked with HDFC Securities Ltd, SMIFS Securities Ltd, C Mackertich, Canbank Financial Services Ltd and Money Market Operations.

Samir Rachh

B.Com

Over 25 years of experience September 2010 onwards RNAM, Fund Manager of - Equity October -2007 to August 2010 RNAM, Senior Analyst involved in research on Select Companies and tracking Few Industries. April 2004 to October 2007 Emkay Global Financial Services Ltd, Head of Research and Portfolio Manager, Heading Research Team and Generating Reports and Ideas,managing PMS Products. April 2003 to March 2004 IndusInd Bank Ltd, Investment Manager, Assisting in fund management and Generating investment ideas. October 1998 to March 2003 Hinduja Finance Ltd, Investment Manager Managing Portion of Company's Investment Book and generating investment ideas

Get your FAQs right

When comparing Nippon India Pharma Fund - Direct (G) vs Nippon India Value Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and Nippon India Value Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Nippon India Pharma Fund - Direct (G) and Nippon India Value Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and Nippon India Value Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Nippon India Pharma Fund - Direct (G) and Nippon India Value Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions